A nasal swab containing a test sample is mixed with a simple lab test. It contains a liquid mixed with gold nanoparticles attached to a molecule that binds to the novel coronavirus. If the virus is present, the gold nanoparticles turns the solution a deep blue color (bottom of the tube) and a precipitation is noticed. If it is not present, the solution retains its original purple color.
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require the use of any advanced laboratory techniques, such as those commonly used to amplify DNA, for analysis. The authors published their work last week in the American Chemical Society’s nanotechnology journal ACS Nano.
“Based on our preliminary results, we believe this promising new test may detect RNA material from the virus as early as the first day of infection. Additional studies are needed, however, to confirm whether this is indeed the case,” said study leader Dipanjan Pan, PhD, Professor of Diagnostic Radiology and Nuclear Medicine and Pediatrics at the UMSOM.
Once a nasal swab or saliva sample is obtained from a patient, the RNA is extracted from the sample via a simple process that takes about 10 minutes. The test uses a highly specific molecule attached to the gold nanoparticles to detect a particular protein. This protein is part of the genetic sequence that is unique to the novel coronavirus. When the biosensor binds to the virus’s gene sequence, the gold nanoparticles respond by turning the liquid reagent from purple to blue.
“The accuracy of any COVID-19 test is based on being able to reliably detect any virus. This means it does not give a false negative result if the virus actually is present, nor a false positive result if the virus is not present,” said Dr. Pan. “Many of the diagnostic tests currently on the market cannot detect the virus until several days after infection. For this reason, they have a significant rate of false negative results.”
Dr. Pan created a company called VitruVian Bio to develop the test for commercial application. He plans to have a pre-submission meeting with the U.S. Food and Drug Administration (FDA) within the next month to discuss requirements for getting an emergency use authorization for the test. New FDA policy allows for the marketing of COVID-19 tests without requiring them to go through the usual approval or clearance process. These tests do, however, need to meet certain validation testing requirements to ensure that they provide reliable results.
“This RNA-based test appears to be very promising in terms of detecting the virus. The innovative approach provides results without the need for a sophisticated laboratory facility,” said study co-author Matthew Frieman, PhD, Associate Professor of Microbiology and Immunology at UMSOM.
Although more clinical studies are warranted, this test could be far less expensive to produce and process than a standard COVID-19 lab test; it does not require laboratory equipment or trained personnel to run the test and analyze the results. If this new test meets FDA expectations, it could potentially be used in daycare centers, nursing homes, college campuses, and work places as a surveillance technique to monitor any resurgence of infections.
In Dr. Pan’s laboratory, research scientist Parikshit Moitra, PhD, and UMSOM research fellow Maha Alafeef conducted the studies along with research fellow Ketan Dighe from UMBC.
Dr. Pan holds a joint appointment with the College of Engineering at the University of Maryland Baltimore County and is also a faculty member of the Center for Blood Oxygen Transport and Hemostasis (CBOTH).
“This is another example of how our faculty is driving innovation to fulfill a vital need to expand the capacity of COVID-19 testing,” said Dean E. Albert Reece, MD, PhD, MBA, who is also Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor, University of Maryland School of Medicine. “Our nation will be relying on inexpensive, rapid tests that can be dispersed widely and used often until we have effective vaccines against this pandemic.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Seychelles: African Development Bank extends $10 million loan to support COVID-19 responses as economy reopenson June 23, 2020 at 11:29 am
The loan will be channeled toward macroeconomic stabilization,strengtheningnational health responses to the COVID-19 pandemic ... help put in placerobust early-detection surveillance systems ...
- ICMR nod to rapid antigen test also for Covid-19 detectionon June 23, 2020 at 11:22 am
The Indian Council of Medical Research (ICMR) on Tuesday recommended newer additional strategies for Covid-19 testing, as it allowed the use of an antigen test to fast-track testing and tracing of ...
- Delayed Cancer Care Due To Covid-19 Could Cost Thousands Of Liveson June 23, 2020 at 11:11 am
The lockdowns undoubtedly saved many lives. But they will increase deaths in ways that will only become apparent afterwards.
- How COVID-19 Has Changed Cybersecurityon June 23, 2020 at 11:00 am
Cybersecurity products are seeing rapid adoption and their stocks have also done well -- is this all sustainable?
- Research project to investigate low-cost, rapid, COVID-19 detection systemon June 23, 2020 at 10:23 am
COVID-19 diagnosis system using nanophotonic fluorescence enhancement. The pilot study led by academics at the University of Bristol will use simulant fluorescently labelled RNA to develop an assay ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Visual detection of Covid-19
- The 5 Most Exciting Things Apple Announced at its Virtual WWDC 2020on June 22, 2020 at 3:04 pm
Aside from the new faces, Apple went on to highlight the newest features coming to its software for its iPhone, iPad, and Apple Watch devices, along with its Apple TV and macOS platforms. On top of ...
- AI Eye Episode 373: NVIDIA Unveils Cyber-AI Platform for Security Threat Detection and Network Protectionon June 22, 2020 at 11:17 am
Watching stock news, deal tracker and advancements in artificial intelligence NVIDIA Corporation ( NasdaqGS:NVDA) has unveiled the NVIDIA Mellanox UFM Cyber-AI platform, which according to the press ...
- HPE to Deliver Five New Return-to-Work Solutions to Help Organizations Accelerate Recovery in Wake of COVID-19on June 22, 2020 at 6:56 am
Hewlett Packard Enterprise (HPE) today announced five new return-to-work solutions that will help organizations accelerate business recovery and reopening plans in the wake of COVID-19. The new ...
- HPE launches return to work, office reopening technologieson June 22, 2020 at 4:45 am
The systems include HPE servers and edge and Aruba gear for things like social distancing monitoring, messaging and fever detection.
- Why the pandemic unleashed a frenzy of toilet-paper buyingon June 19, 2020 at 4:18 am
Personality traits help to explain why some people and not others hoarded a humdrum product in the face of a deadly virus.